Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9849 - 9856 of 12085 results

FTC Review of Medtronic Acquisition Focuses On Future Competition
January 26, 2015| Blog| Viewpoint

Health Care Enforcement in 2015: A Look Back at 2014 and Forecasting the Year Ahead
January 26, 2015| Blog| Viewpoint

OIG Defends Its Hospital Compliance Reviews in Response to AHA Criticism
January 26, 2015| Blog| Viewpoint

Reference Chart of Proposed Amendments to Medicare Shared Savings Program
January 26, 2015| Blog| Viewpoint

Privacy Monday - January 26, 2015
January 26, 2015| Blog| Viewpoint

2014 Cleantech and Renewables IPO Statistics
January 26, 2015| Article| Viewpoint

Don’t Even Think About Advertising a SUPER BOWL Party!
January 26, 2015| Blog| Viewpoint

Massachusetts Adopts Intrastate Crowdfunding Rules, Effective Immediately
January 26, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
